Bausch Health Companies | VRX - Bruttoergebnis Vom Umsatz

Aktienkurs
7.89
Täglich Wechseln
0.12 1.54%
Monatlich
14.68%
Jährlich
31.28%
Q2 Prognose
7.59




Bruttoergebnis Vom Umsatz Veränderung Datum
Amgen USD 6.48B 307M 2025-09
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Bausch Health Companies USD 1.93B 165M 2025-09
Biogen USD 1.65B 34.6M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Canopy Growth CAD 21.47M 434K 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Danaher USD 3.97B 443M 2025-12
Drreddys Laboratories INR 46.81B 10.24B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novo Nordisk DKK 64.01B 1.19B 2025-06
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Phibro Animal Health USD 133.5M 12.6M 2025-12
Prestige Brands USD 157.37M 5.79M 2025-12
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Zoetis USD 1.64B 73M 2025-12